Use of the Fetal Fibronectin Test in Decisions to Admit to Hospital for Preterm Labor

Clinical Chemistry

Volumn 50, Issue 3, 2004, Pages 663-665

  Foxman, Ellen F ^a   Jarolim, Petr ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FETOPROTEIN; FIBRONECTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HOSPITAL ADMISSION; HUMAN; MEDICAL DECISION MAKING; PREMATURE LABOR; PREMATURITY; TOCOLYSIS;

ADULT; DECISION MAKING; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HUMANS; OBSTETRIC LABOR, PREMATURE; PATIENT ADMISSION; PREGNANCY;

EID: 1542290170     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.028720     Document Type: Article

References (5)

1. Ascarelli MH, Morrison JC. Use of fetal fibronectin in clinical practice [Review]. Obstet Gynecol Surv 1997;52:S1-12.
2. Peaceman AM, Andrews WW, Thorp JM, Oliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997;177:13-8.
3. Luzzi V, Hankins K, Gronowski AM. Accuracy of the rapid fetal fibronectin TLi system in predicting preterm delivery. Clin Chem 2003;49:501-2.
4. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: a systematic review. BMJ 2002;325:301-10.
5. Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999;180:581-6.